Table 2

Research agenda

ItemResearch area
1.To address the large imbalance in the available evidence across the diseases within the scope of these recommendations, more high quality studies are needed on SLE, PsA, SSc and gout for all the lifestyle exposures included in this TF. Larger, high-quality studies are needed for all RMDs on certain lifestyle exposures (such as diet, where effect sizes are likely to be small).
2.To understand the synergistic effect of multiple lifestyle improvements on disease progression.
3.To gain a greater understanding of the effect of socioeconomic deprivation on the associations between lifestyle factors and the outcomes assessed in this TF.
  • PsA, psoriatic arthritis; RMDs, rheumatic and musculoskeletal diseases; SLE, systemic lupus erythematosus; SSc, systemic sclerosis; TF, taskforce.